Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Overall Management Female by Year
Overall Management Female (%) (%)
Novartis Overall Management Female: 49.0% in FY2025, up 1.0 pts from a year earlier.
Latest, FY2025
49.0%
Period ended Dec 31, 2025
Change on a year earlier
+1.0 pts
48.0% in FY2024
History
3 years
Since FY2023
Sources
2
Documents cited below
Where the FY2025 figure comes from
“| Overall management | 49 / 51 | 48 / 52”
Source: Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗
Reported in ESG Data Summary 2025.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Overall Management Female (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 49.0% | +1.0 pts | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
| FY2024 | Dec 31, 2024 | 48.0% | 0.0 pts | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
| FY2023 | Dec 31, 2023 | 48.0% | – | Novartis Form 6-K (0001370368-25-000008) ↗ |
Cite this data
StockData. (2026). Novartis Overall Management Female (%), annual FY2023–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/wf-female-mgmt-pct
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.